Back
BioNTech SE 10K Form
Sell
29
BNTX
BioNTech SE
Last Price:
84.36
Seasonality Move:
28.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNTX News And Ratings
See the #1 stock for the next 7 days that we like better than BNTX
BNTX Financial Statistics
Sales & Book Value
| Annual Sales: | $4.13B |
|---|---|
| Cash Flow: | $-493.35M |
| Price / Cash Flow: | 3.81 |
| Annual Sales: | $90.71 |
| Price / Book: | 0.95 |
Profitability
| EPS (TTM): | 0.48050 |
|---|---|
| Net Income (TTM): | $118.1M |
| Gross Margin: | $3.49B |
| Return on Equity: | 0.54% |
| Return on Assets: | 0.49% |
BioNTech SE Earnings Forecast
Key BioNTech SE Financial Ratios
- The Gross Profit Margin over the past 7 years for BNTX is 84.29%.
- The Selling, General & Administrative Expenses for BNTX have been equal to 14.60% of Gross Profit Margin.
- The Research & Development expenses have been 46.69% of Revenue.
- The Interest Expense is 0.17% of Operating Income.
- The Net Earning history of BNTX is 24.36% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
BioNTech SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BNTX |
| CUSIP: | 09075V |
| Website: | biontech.de |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 11.38 |
| Quick Ratio: | 10.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.41 |
|---|---|
| Forward P/E Ratio: | 0 |
BNTX Technical Analysis vs Fundamental Analysis
Sell
29
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy or a Sell?
-
BioNTech SE stock is rated a Sell
The current BioNTech SE [BNTX] share price is $84.64. The Score for BNTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.